Trial intelligence / Profile preview

Adebrelimab Combined With Simvastatin, Targeted Therapy, and Chemotherapy for First-line MSS/pMMR Advanced Colorectal Cancer

NCT07718490Phase 2Recruiting

Sponsor
Jiangsu Provincial People's Hospital
Start
Sep 2025
Primary completion
Dec 2027
Countries
1
01

Overview

A Phase 2 trial of adebrelimab in colorectal cancer (CRC), sponsored by Jiangsu Provincial People's Hospital. Started Sep 2025; status: recruiting.

02

Drugs

adebrelimab
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT07718490.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07718490.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call